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Abstract 
Sudden death of healthy young adults in the absence of any medical reason is generally 
categorized as autopsy-negative sudden unexplained death (SUD). Approximately 30% of all 
SUD cases can be explained by lethal sequence variants in cardiac genes causing disturbed 
ion channel functions (channelopathies) or minimal structural heart abnormalities 
(cardiomyopathies). 
The aim of this study was to perform whole-exome sequencing (WES) in five young SUD 
cases in order to identify potentially disease-causing mutations with a focus on 184 genes 
associated with cardiac diseases or sudden death.  
WES analysis enabled the identification of damaging-predicted cardiac sequence alterations 
in three out of five SUD cases. Two SUD victims carried disease-causing variants in long QT 
syndrome (LQTS)-associated genes (KCNH2; SCN5A). In a third case, WES identified 
variants in two genes involved in mitral valve prolapse and thoracic aortic aneurism (DCHS1; 
TGFβ2). The genome of a fourth case carried several minor variants involved in arrhythmia 
pointing to a multigene influence that might have contributed to sudden death.  
Our results confirm that post-mortem genetic testing in SUD cases in addition to the 
conventional autopsy can help to identify familial cardiac diseases and can contribute to the 
identification of genetic risk factors for sudden death.  
 
Keywords: sudden unexplained death, cardiac diseases, molecular autopsy, whole-exome 
sequencing  
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Introduction 
Sudden death (SD) of a previously healthy adolescent or young adult is a tragic and 
distressing event for those left behind. Depending on the underlying cause of death, SD can 
be divided into sudden cardiac death (SCD) or sudden death due to non-cardiac causes such 
as pulmonary embolism, metabolic, neurological or infectious conditions [1,2]. In elderly 
persons, SCD is mainly caused by coronary artery disease (CAD), whereas in young people 
(between 1 to 39 years of age), a complete post-mortem examination fails to reveal a cause of 
death in up to 30% of all cases [3,4]. These are generally designated as autopsy-negative 
sudden unexplained death (SUD) cases. Although SCD is one of the major causes of mortality 
worldwide, the exact incidence of SUD in young individuals remains unknown in most 
countries [5,6]. 
It is estimated that up to 30% of all SUD cases carry sequence variants in known cardiac 
genes causing lethal cardiac arrhythmia in a morphological normal heart. [3,7,8]. 
Channelopathies primarily affect the heart rhythm and cardiac electrical conduction including 
cardiac diseases such as long QT syndrome (LQTS), short QT syndrome (SQTS), 
catecholaminergic polymorphic ventricular tachycardia (CPVT), Brugada syndrome (BrS), 
and idiopathic ventricular fibrillation [9]. Cardiomyopathies on the other hand refer to 
myocardial disorders characterized by a structural and functional abnormal heart muscle [10]. 
The most common form is hypertrophic cardiomyopathy (HCM) followed by other 
cardiomyopathies such as arrhythmogenic right ventricular cardiomyopathy (ARVC), 
idiopathic dilated cardiomyopathy (DCM), and left ventricular non-compaction 
cardiomyopathy (LVNC) [11].  
Post-mortem genetic testing by using specific gene panels or whole-exome sequencing (WES) 
represents an efficient tool to elucidate potential disease-causing mechanisms, which 
remained undetected during autopsy [8,12,13]. The exome represents approximately 1-2% of 
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the human genome, but it accounts for over 85% of all mutations that have been identified in 
Mendelian disorders [14]. Loporcaro et al. recently published a first proof-of-principle case 
report of a WES-based comprehensive molecular autopsy of an otherwise healthy 16-year-old 
SUDY (SUD in the young) victim, where they identified a pathogenic MYH7 mutation, 
previously described in familial HCM, sudden death, and impaired MHC-β actin-translocating 
and actin-activated ATPase activity [12]. Further studies described the detection of eight 
ultra-rare variants in seven of 14 Caucasian SUDY victims by focusing on 117 sudden death-
susceptibility genes and the identification of likely pathogenic variants in 34 genes in 20% of 
forensic SUD cases [8,15]. Post-mortem genetic analysis of SUD victims may not only enable 
an accurate determination of cause and manner of death, but may also have significant impact 
for affected living first-degree family members in whom death-predisposing disorders had 
remained unrecognized so far [16,17].  
At the Zurich Institute of Forensic Medicine (ZIFM), University of Zurich, Switzerland, 
approximately 10 sudden death cases in young individuals are reported annually to show no 
or only minor morphological abnormalities during autopsy, leaving those left behind without 
any explanation about the exact cause of death. WES is not substantially more expensive than 
a targeted approach using a gene panel, but allows additional examination of new candidate 
genes in case of a negative result within the predefined gene list. In this study, we performed 
WES analyses in five unrelated SUD cases by focusing on 184 cardiac disease-associated 
genes. We wanted to test whether such a procedure could be implemented as a standard 
operating procedure to investigate or uncover lethal cardiac diseases. 
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Material and Methods 
Five unrelated sudden unexplained death cases (4 females and 1 male) were collected between 
March and May 2012 at the ZIFM, Switzerland. All SUD cases were examined according to 
standard forensic procedures, including death scene investigation, a complete autopsy 
examination with pharmacological-toxicological and histopathological screening, and review 
of the clinical history. Inclusion criteria were: (1) younger than 40 years of age, (2) only 
minor abnormalities in the heart, and (3) suspicion of an inherited cardiac disease or 
underlying cardiac arrhythmia contributing to sudden death. DNA of first-degree relatives of 
the 5 SUD cases was not available for co-segregation analysis.  
Ethical approval 
Ethical approval for this study was provided by the local committee in Zurich (KEK-ZH-Nr. 
2013-0086), and the study was conducted in full conformance with Swiss laws and 
regulations.  
DNA sample collection and extraction 
5ml EDTA blood samples from the 5 SUD cases were collected during autopsy and were 
stored at -20° C. Genomic DNA was extracted using the Gentra Puregene Blood Kit (Qiagen, 
Hombrechtikon, CH) according to the manufacturer’s protocol and quantified using the 
NanoDrop2000 (Fischer Scientific, Wohlen, CH).  
Exome sequencing  
Exome capture, sequencing as well as sequence alignment and variant calling were performed 
at Atlas Biolabs (Berlin, DE). Nimblegen SeqCap EZ Human Exome Library v.2.0 (Roche 
NimbleGen Inc., Madison, USA) was used for library preparation and sequencing was done 
on the Illumina HiSeq2000 platform (Illumina Inc., San Diego, USA) generating 2x100bp 
paired-end reads [18]. Alignment of sequence reads, indexing of the reference genome (hg19), 
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variant calling and annotation was done with a pipeline based on BWA [19], Samtools [20], 
Picard and Annovar [21]. 
Filtering steps and data analysis  
Variant filtering included a gene panel of 184 genes associated with cardiac diseases or 
cardiac death (Supp. Table S1). Annotation of these genes was conducted with the software 
Alamut HT version 1.1.7 (Interactive Biosoftware, Rouen, F). Output results were imported 
into an excel-sheet for further analysis. At first, variants were checked manually if they are 
disease-associated according to entries from the Human Gene Mutation Database Professional 
(HGMD
®
) (BIOBASE GmbH, Wolfenbüttel, DE) (Fig. 1). To include known modulator and 
risk factor variants into data analysis, HGMD
®
-reported variants were not filtered for a 
threshold minor allele frequency (MAF). The filtering steps for all other variants focused on 
(1) a global MAF value less than or equal to 0.02 (based on dbSNP), (2) exonic and splice site 
(+1, +5) variants, (3) exonic InDels, missense, and nonsense variants, and (4) deleterious or 
damaging protein predicted functions according to the following in silico predictive 
algorithms: MAPP (multivariate analysis of protein polymorphism prediction), SIFT (sorting 
intolerant from tolerant prediction), PolyPhen2 and MutationTaster. Sequence alterations at 
the 5’ donor splice sites +1 and +5 were included into data analysis, because variants at these 
positions are thought to significantly reduce the pairing of the donor splice site with the 
complementary site in the small nuclear ribonucleoprotein particle U1snRNP, which is one of 
the first steps in the complex process of mRNA splicing [22]. Alamut Visual version 2.4.7 
(Interactive Biosoftware, Rouen, F) was used to visualize the coverage of variants and to 
review conservation of the variants across a variety of species (based on Ensembl Genome 
Browser, http://ensembl.org). Global allelic frequencies were examined in dbSNP at NCBI 
(www.ncbi.nlm.nih.gov/projects/SNP/), Ensembl and in the exome aggregation consortium 
database ExAC (http://exac.broadinstitute.org/).  
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Possible disease-causing variants must be absent or rare in public databases (dbSNP, ExAC) 
or in 288 analysed controls (177 males, 111 females) from the general Swiss population. 
As a final step, genes identified with disease-causing variants were analysed for splice site 
and/or synonymous variants. 
Confirmation and validation of variants 
Potential disease-causing variants found in whole-exome sequencing data of the 5 SUD cases 
were confirmed and screened in 288 controls by using standard polymerase chain reaction 
(PCR) and Sanger sequencing methods (primer sequences available on request). Sequence 
data were aligned to the reference sequence with the SeqScape
®
 software version v2.6 (Life 
Technologies, Rotkreuz, CH) (supplementary data).  
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Results 
Whole-exome sequencing was performed in five unrelated SUD cases. Data were analysed 
with respect to sequence variants with a focus on 184 genes previously associated with 
cardiac diseases or cardiac death. WES yielded an average of 87 433 402.8 total reads and 
87.44 % of the target positions were covered at least 30x (Table 1). Within the exome 
sequencing data, the five cases had on average 40 658 ± 613.2 single nucleotide variants 
(SNV) and insertion/deletions (InDels) causing amino acid changes (missense variants) on 
average in 10 788.4 ± 162.2 variants. By focusing only on the cardiac gene panel, on average 
633.2 ± 10.6 variants were obtained per case. After all filtering steps, 23.4 ± 6.3 variants were 
used for further manual evaluation.   
Case I 
Case I was a 27-year-old woman (weight, 54.1kg; height, 172cm; European origin) found 
death on a sofa by her roommate late in the evening. Autopsy investigations showed a normal 
heart size (330g) according to Zeek [23], but a swollen and oedematous mitral valve with 
connective tissue changes in papillary muscles and thickening of tendinous chords (Supp. Fig. 
S1a) Histological examination of the mitral valve revealed thickening and mucoid swelling of 
the tissue with signs of collagenous destruction (Supp. Fig. S1b). Microbiological, virological, 
and pharmacological-toxicological screening results were all negative and showed no signs of 
an acute inflammation prior to death.  
At least two potential disease-causing heterozygous variants were detected in the 27-year-old 
woman (Table 2). A missense variant was located in the dachsous cadherin-related 1 gene 
(DCHS1; NM_003737.2: c.3415C>T: p.Arg1139Cys) with disease-causing protein function 
predictions and an allele frequency of 3.7e-05 in the general population (ExAC). The second 
variant was a one nucleotide, frame-shifting deletion in the transforming growth factor beta 2 
gene (TGFβ2; NM_001135599.2: c.440delC: p.Pro.147fs*27) leading to a truncated protein, 
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not previously described in respective databases or in the scientific literature. The ancestral 
alleles of both variants were highly conserved during evolution.  
Case II 
Case II was a 30-year-old woman (weight, 51.6kg; height, 166cm; European origin). She 
collapsed in the bathroom and was brought into her bed, where she died shortly afterwards. 
She had severe depression and was alcohol-dependent. Chemical screening tests detected a 
massively increased amount of butyric acid (almost lethal concentration of 2500μmol/L) and 
further pathological metabolic products such as acetone. Pharmacological-toxicological 
screening tests detected therapeutic concentrations of benzodiazepines in peripheral blood. 
Autopsy investigations showed a heart weight of 390g (24% enlarged according to Zeek) with 
an adipose right ventricle and focally enlarged myocytes. 
Within the 184 cardiac genes, we found at least two important possibly phenotype-relevant 
heterozygous missense variants (Table 2). One variant (rs76906304) was located in the gap 
junction protein delta 4 gene (GJD4; NM_153368.2: c.259C>T: p.Leu87Phe). The second 
variant was detected in the junctophilin type 2 gene (JPH2; NM_020433.4: c.1013A>G: 
p.Glu338Gly), not previously described in the literature or public databases. Both variants 
were predicted to be disease-causing/damaging according to the in silico predictive 
algorithms.  
Case III 
Case III was a 31-year-old man (weight, 87.6kg; height, 186cm; European origin) who was 
found dead sitting on the toilet in his apartment. He worked in a restaurant kitchen, but did 
not appear to his working shift although he was seen shortly before and was considered to be 
reliable. On the evening before, he has attended a concert with some colleagues where they 
allegedly consumed different drugs. The autopsy showed a moderate enlarged heart (390g) 
without further morphological abnormalities. Post-mortem pharmacological-toxicological 
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screening results were positive for cannabis and amphetamine. Further investigations of the 
medical history revealed a long QT syndrome (LQTS) diagnosis which was already detected 
in his adolescence based on electrocardiography (ECG) results (Supp. Fig. S2). His physician 
recommended an annual medical check including an ECG stress test, but he did not prescribe 
any medications. Two of the deceased’s brothers and mother had the same diagnosis of 
LQTS, but without any implications so far (Supp. Fig. S3). 
Within the cardiac gene panel, we found two nonsense alterations and two missense variants 
(Table 2). One stop variant (rs121912509) was detected in the gene encoding the potassium 
voltage-gated channel, subfamily H, member 2 (KCHN2; NM_000238.3: c.3002G>A: 
p.Trp1001*), reported as a LQT2 disease-causing mutation according to HGMD
®
. Due to low 
number of reads (coverage = 6) at this position, Sanger sequencing was performed to confirm 
the variant (supplementary data). A second stop variant (rs140704891) was identified in the 
RAN guanine nucleotide release factor gene (RANGRF; NM_016492.4: c.181G>T: p.glu61*) 
and is classified as an in vitro or in vivo functional polymorphism in HGMD
®
. Two 
potentially disease-relevant heterozygous missense variants were located in the desmoplakin 
gene (DSP; NM_004415.2: rs78652302: c.5498A>T: p.Glu1833Val) and in the myosin heavy 
chain 7 gene (MYH7; NM_000257.2: rs3729823: c.4472C>G: p.Ser1491Cys). Both variants 
were described as possible disease-causing mutations according to HGMD
® 
(rs78652302: 
dilated cardiomyopathy and rs3729823: hypertrophic cardiomyopathy) and protein effects 
were predicted to be deleterious (SIFT), probably damaging (polyphen2) and disease-causing 
(MutationTaster). MAF for both variants is ~1% in the general population, but shows a 
variable frequency within the European population (Ensembl: rs78652302: 1-3%T and 
rs3729823: 0-3%G). 
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Case IV 
Case IV was a 38-year-old woman (weight, 58.8kg; height, 162cm; Tibetan origin). She was 
found dead in the morning by her ten-year old daughter who was sleeping in the same bed. 
Since several weeks, the woman complained about the air conditioner at her new job as she 
had a cold, but was otherwise healthy. Autopsy findings showed a normal heart size (250g) 
and a slightly fatty infiltrated right ventricle without any further morphological abnormalities. 
Family history was negative for cardiac diseases or sudden death.  
Genetic testing identified no rare disease-causing sequence variants within the cardiac gene 
panel, but the woman had several minor variants which probably affect function (Table 2). 
One heterozygous missense variant was located in KCNH2 (rs1805123: c.2690T>G: 
p.Lys897Thr) and is associated with atrial fibrillation and drug induced arrhythmia according 
to HGMD
®
. Although the minor allele is common in the European population (20%G), the 
variant is significantly less common in the Asian population (4%G). Further heterozygous 
missense variants were located in DSP (rs28763971: c.8605A>G: p.Ille2869Val), in the 
potassium voltage gated channel, KQT type gene (KCNQ1; NM_000218.2: rs12720449: 
c.1343C>G: p.Pro448Arg) and in the sodium channel type 10 gene (SCN10A; NM_006514.2: 
rs148041371: c.3291C>G: p.Ille1097Met). Although all three sequence variants are very rare 
in the European population, they are much more common in the Asian population (Ensembl: 
rs28763971: 2%G; rs12720449: 11%G; rs148041371: 2%G). 
Case V 
Case V was a 19-year-old woman (weight, 68.4kg; height, 170cm; European origin) who gave 
birth to her first child two months before she died. She had a minor cough, but was otherwise 
healthy when she suddenly collapsed at her home. The ambulance transferred her to the 
hospital where life-sustaining measures were stopped after the diagnosis of myocardial 
infarction and irreversible brain damage. Autopsy investigation showed a broadening and 
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fatty infiltrated right ventricle possibly indicating ARVC (Supp. Fig. S4 a,b), and the heart 
was slightly enlarged (300g). Pharmacological-toxicological screening tests were negative for 
drugs and alcohol. Further investigations of the family history showed that a niece of the 
deceased died suddenly at the age of 11 during sports and the grandfather died suddenly while 
sweeping snow at the of age of 77 (Supp. Fig. S5). Furthermore, her mother had minimal 
prolongation of the heart rate corrected QT intervals (QTc) of 460-480 ms [24]; however she 
did not follow further medical examinations. The toddler of this young woman has been under 
medical observation, a QTc prolongation (495ms) has been detected during sleep, but the 
echocardiogram was normal. 
Analysis of sequence variants within the 184 cardiac genes revealed two heterozygous 
variants in the voltage-gated sodium channel type V, alpha subunit (SCN5A) (Table 2). One 
missense variant was located in exon 28 (NM_001099404.1: c.5320A>C, p.Asn1774His) and 
was not previously reported in the literature and in public databases. A second missense 
variant was located in exon 12 (NM_001099404.1: rs1805124, c.1673A>G, p.His558Arg) 
and is described as disease-associated polymorphism with additional supporting functional 
evidence according to HGMD
®
. However, prediction algorithms described the variant as 
tolerated and MAF is 21% in the general population.  
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Discussion 
Molecular testing in autopsy-negative death cases can identify the underlying mechanisms for 
sudden death and may represent an efficient tool in combination with standard forensic 
investigations to identify or confirm the suspicion of an inherited sudden death-predisposing 
disorder [8].  
In this study, genetic testing by using WES enabled the identification of potential lethal 
cardiac disease-associated alterations in three out of five SUD victims (Table 3). A fourth 
case carried several minor variants pointing to a multigene influence instead of a strong 
autosomal dominant sequence variant which could explain the phenotype.  
Case I had one missense variant in DCHS1 (p.Arg1139Cys) and a one nucleotide frame-shift 
deletion in TGFβ2 (p.Pro.147fs*27). Sequence variants in both genes were already reported in 
mitral valve prolapse (MVP), which is a valvular heart disease characterized by the 
displacement of an abnormally thickened mitral valve leaflet into the left atrium during 
systole leading to serious complications, including arrhythmia, heart failure, and sudden death 
[25]. Reanalysis of the case report showed that the young woman had scoliosis and was very 
tall with long, slender limbs and fingers. Point mutations and whole-gene 
deletions/duplications in TGFβ2 are reported in patients with Loeys-Ditz syndrome (LDS), 
familial thoracic aortic aneurysms and acute aortic dissection (TAAD) associated with mild 
systemic features of Marfan syndrome (MFS) [26]. Phenotypical features and genetic testing 
strongly indicated that the young woman had an underlying connective tissue disease, 
obviously not diagnosed during her lifetime, which might have contributed to mitral valve 
prolapse leading to the sudden death of this young woman.  
WES analysis in case II identified two variants in GJD4 (p.Leu87Phe) and JPH2 
(p.Glu338Gly). Connexins, such as GJD4, are transmembrane proteins involved in the 
formation of gap junction channels in the heart. Alterations in the connexin family are 
associated with cardiac arrhythmias and sudden infant death syndrome (SIDS) [27,28]. 
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Junctophilin type 2 is a cardiac member of junctional membrane complex proteins and JPH2 
knockout mice demonstrated embryonic lethality and irregular calcium handling suggesting a 
crucial role for junctophilin-2 in facilitating intracellular calcium release and cardiac 
contractility [29]. Sequence variants in JPH2 were reported in atrial fibrillation due to 
impaired ryanodine receptor Ca
2+ 
channels (RyR2) stabilization and in familial HCM [30]. 
Although primary cause of death in this young woman was already diagnosed due to 
metabolic imbalance, the two GJD4 and JPH2 variants could have contributed to the 
morphological abnormalities in her heart triggering the sudden death event during a critical 
time period. 
Case III carried two nonsense sequence variants in RANGRF (p.glu61*) and KCNH2 
(p.Trp1001*). RANGRF protein regulates the expression and function of SCN5A (Nav1.5) 
cardiac sodium channel. Electrophysiological studies in CHO-K1 cells demonstrated that the 
p.Glu61* stop completely failed to increase the sodium channel current compared to wild-
type and may increase the risk of arrhythmias [31]. The Nav1.5 interacting part of RANGRF 
is positioned in the amino acid range 65-186 and hence a truncated protein produced from the 
affected allele would presumably not bind to the Nav1.5 leading to a loss of function [32]. 
KCNH2 encodes the pore forming subunit of the rapidly activating delayed rectifier K
+ 
channel (IKr) in the heart. Sequence variants are associated with delayed cardiac repolarization 
and prolonged QTc intervals leading to ventricular arrhythmias and sudden death [33]. The 
stop variant (c.3002C>T; p.Trp1001*) affects the C-terminus region of the KCNH2 protein 
leading to assembly abnormality caused by a reduction of mutant mRNA transcripts by 
nonsense-mediated mRNA decay [34]. The p.Trp1001* could be the major underlying 
pathogenic sequence alteration causing QTc interval prolongation in this young man 
confirming the ECG-based clinical diagnosis of LQTS. In addition, QTc interval prolongation 
is described in patients taking amphetamine-type stimulants [35], also detected in therapeutic 
concentration in this 31-year-old man.  
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Genetic testing in case IV identified one variant in KCNH2 (p.Lys897Thr) and several 
borderline variants in arrhythmia-associated genes (DSP: p.Ille2869Val; KCNQ1: 
p.Pro448Arg; SCN10A: p.Ille1097Met). Although sequence variants in KCNH2 are described 
in drug-induced QTc prolongation [36], we have no evidence if the woman was taking any 
medications against her cold prior to death. The common p.Lys897Thr is associated with an 
increased risk of developing torsade de pointes in the subacute phase of myocardial infarction 
and is described as a genetic modifier of latent congenital LQTS [37,38]. Furthermore, cases 
with multiple borderline variants are more susceptible to develop diseases, even in absence of 
strong dominant mutations that explain the phenotype. One major problem during data 
analysis was that the allelic frequencies of Tibetan origin were not available in public 
databases, complicating accurate interpretation of the found sequence variants.  
Case V carried a missense variant in SCN5A (p. Asn1774His) not previously reported in 
public databases. Kato et al. described a one-day old boy with prolonged QTc intervals 
(680ms) having asparagine to aspartic acid replacement at the same position (rs199473633, 
c.5320T>C, p.Asn1774Asp) and his brother died suddenly in infancy [39]. A functional assay 
demonstrated that p.Asn1774Asp channels carried significantly larger late components of 
sodium current than wildtype cells. The same amino acid replacement (p.Asn1774Asp) was 
also reported in a male foetus, which showed typical clinical signs of LQT3 (convulsion, 
ventricular tachycardia, torsade de pointes, atrioventricular block and QTc intervals of 670 
ms) [40]. To investigate the consequences of the asparagine to histidine amino acid change 
found in this young woman, functional studies are required in order to study the biological 
relevance of this substitution. The second missense variant in SCN5A (p.His558Arg) is 
described as phenotype modifier in LQTS and might amplify or modulate the functional 
electrophysiological impairment of genetic variants located in the same gene [41,42]. Genetic 
analysis could not confirm a suspected ARVC although histopathological findings indicated 
clear fibro-fatty tissue infiltration with replacement of myocardium in the right ventricle. 
16 
 
Approximately 50% of ARVC cases remain negative after genetic testing. This might be 
explained by the complex genetic background of ARVC and low penetrance making it 
difficult to identify the true disease-causing variants accurately [43]. In summary, 
morphological abnormalities in the heart led to an ARVC suspicion during autopsy, however 
genetic testing could not confirm this suspicion but indicated a possible disturbed ion channel 
function. In the end, both of them could have contributed to cardiac arrhythmias triggering her 
lethal cardiac infarction. 
WES is one of the most commonly used new sequencing approaches and major advantages 
are a high throughput, well established sample preparation methods and relatively low 
preparation and sequencing costs compared to traditional Sanger sequencing [44]. 
Additionally, sample preparation and sequencing can be performed from small input amount 
of DNA, which can be crucial for post-mortem samples where the amount of available tissue 
and the DNA quality are limited. Library preparation and sequencing costs are comparable to 
a targeted gene approach, but the WES data analysis can be extended to the whole exome in 
order to identify new candidate genes in cases where the analysis remained negative within a 
predefined gene panel.    
Significant challenges in WES represent the handling and processing steps of such huge 
amount of sequencing data, which requires a variety of computational and statistical 
approaches [45]. Consequently, sequencing data analysis and mainly interpretation are time-
consuming and require expertise in the field to prevent false-positive or false-negative results. 
Although filtering strategies and protein prediction tools can help to interpret the 
pathogenicity of variants, pathological and functional consequences of variants often remain 
unclear and require further functional studies [46]. Negative genetic testing otherwise may be 
secondary to disease-causing sequence variants within genes not included in the cardiac gene 
panel, due to sequence alterations not detectable in WES approaches, such as deep intronic or 
splice mutations, or due to variants lost during bioinformatics steps rather than due to real 
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absence of any sequence alterations. Accurate interpretation is even more difficult in complex 
multifactorial phenotypes such as in sudden unexplained death cases without any obvious 
morphological abnormalities and lethality may be triggered by different events such as stress, 
drugs, or physical exertion [47].   
The legal and ethical aspects of genetic analysis in forensic post-mortem investigations are 
complex, as the main forensic purpose is to determine the cause of death and not its 
implications for surviving relatives [48]. Therefore, genetic counselling of family members 
should be based on a multidisciplinary approach involving forensic pathologists, geneticists 
and cardiologists to provide the family an opportunity to be informed in case of positive 
findings and offering them further clinical evaluation. Nowadays, minor preventive measures 
such as lifestyle modifications, prophylaxis, drug therapy, and implantable defibrillators are 
available in most cardiac diseases preventing another tragedy within the family [2]. In this 
study, genetic counselling of first-degree relatives was performed in two of the cases with 
potential disease-causing variants (case III and case V), whereas the relatives of the other 
three cases were not available for counselling. Furthermore, functional studies to confirm the 
pathogenicity of found variants and family co-segregation analysis would have been crucial to 
verify the possible disease-causing impact of the observed variants, which are potential 
limitations of this study. DNA from family members of the 5 SUD cases was not available for 
co-segregation analysis and hence, it is unknown if the observed variants were inherited from 
the parents or occurred de novo in the deceased.  
In general, post-mortem genetic testing demonstrates an efficient strategy to investigate the 
cause of death in autopsy-negative sudden death cases. However, one of the major challenges 
remains the data management and variant interpretation of the huge amount of exome 
sequencing data and results should be regarded with caution.  
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Title and legends to figures 
Fig. 1 Filtering flow chart. Whole-Exome sequencing data were filtered for 184 genes 
associated with cardiac diseases and/or sudden death. At first, variants were checked in 
HGMD
®
 (Human Genome Mutation Database Professional) for reported variant classes (filter 
2A). The filtering steps for all other variants focused on a global MAF less than 0.02 (filter 
2B), exonic and splice site variants (filter 3), InDels, missense and nonsense variants (filter 4) 
and deleterious or disease-causing protein prediction (filter 5) 
Supp. Fig. S1 Post-mortal data of case I a Sliced mitral valve with oedematous swollen 
leaflets (red arrows) and thickening of chordae tendineae (black arrows). b Alcian blue-PAS 
staining of the mitral valve (tenfold enlargement) showing mucoid swelling of the tissue with 
signs of collagenous destruction 
Supp. Fig. S2 Electrocardiogram of case III. 12-lead electrocardiogram obtained previously 
on this patient showing bradycardia sinus rhythm, HR 53Xmin, notched T waves (typical in 
LQTS2) and abnormal QTc of 520 msec 
Supp. Fig. S3 Pedigree of case III. The 31-years-old index case is indicated with an arrow. 
Two of his brother’s and his mother had the same QTc-prolonged diagnosis based on ECG, 
but are without any implications so far. The grandfather of the deceased had a myocardial 
infarction with 50 years of age 
Supp. Fig. S4 Post-mortal data of case V a Sliced right ventricle showing fatty infiltration 
and rarefied myocardium. b Haematoxylin-eosin staining of the right ventricle showing 
massively fatty infiltration with loss of myocardium 
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Supp. Fig. S5 Pedigree of case V. The 19-year-old index case is indicated with an arrow. The 
niece of the 19-years-old deceased died suddenly at the age of 11 during sports and the 
grandfather died suddenly while sweeping snow at the age of 77. Furthermore, the mother and 
the toddler of the young woman were diagnosed with minimal QTc prolongations 
